Patent Dimensions in the Development and Production of COVID-19 Vaccines

Patent Dimensions in the Development and Production of COVID-19 Vaccines

Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&am...

Full description

Bibliographic Details
Main Authors: Tobias Volpert, Marcel Riepe
Format: Article
Language:deu
Published: Springer 2021-05-01
Series:Wirtschaftsdienst
Online Access:https://doi.org/10.1007/s10273-021-2923-4
id doaj-ad84bc85ca3e469391306c95f20bdf19
record_format Article
spelling doaj-ad84bc85ca3e469391306c95f20bdf192021-05-23T11:23:45ZdeuSpringerWirtschaftsdienst0043-62751613-978X2021-05-01101538739310.1007/s10273-021-2923-4Patent Dimensions in the Development and Production of COVID-19 VaccinesTobias Volpert0Marcel Riepe1VWL, Hochschule Hamm-LippstadtVWL, Hochschule Hamm-LippstadtAbstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&D expenses. On the other hand, patents can be harmful in a sequential development process as they monopolise knowledge that might become a basis for further research. Economic policy cannot resolve this dilemma, but the various dimensions of a patent system can provide a starting point in mitigating a trade-off.https://doi.org/10.1007/s10273-021-2923-4
collection DOAJ
language deu
format Article
sources DOAJ
author Tobias Volpert
Marcel Riepe
spellingShingle Tobias Volpert
Marcel Riepe
Patent Dimensions in the Development and Production of COVID-19 Vaccines
Wirtschaftsdienst
author_facet Tobias Volpert
Marcel Riepe
author_sort Tobias Volpert
title Patent Dimensions in the Development and Production of COVID-19 Vaccines
title_short Patent Dimensions in the Development and Production of COVID-19 Vaccines
title_full Patent Dimensions in the Development and Production of COVID-19 Vaccines
title_fullStr Patent Dimensions in the Development and Production of COVID-19 Vaccines
title_full_unstemmed Patent Dimensions in the Development and Production of COVID-19 Vaccines
title_sort patent dimensions in the development and production of covid-19 vaccines
publisher Springer
series Wirtschaftsdienst
issn 0043-6275
1613-978X
publishDate 2021-05-01
description Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&D expenses. On the other hand, patents can be harmful in a sequential development process as they monopolise knowledge that might become a basis for further research. Economic policy cannot resolve this dilemma, but the various dimensions of a patent system can provide a starting point in mitigating a trade-off.
url https://doi.org/10.1007/s10273-021-2923-4
work_keys_str_mv AT tobiasvolpert patentdimensionsinthedevelopmentandproductionofcovid19vaccines
AT marcelriepe patentdimensionsinthedevelopmentandproductionofcovid19vaccines
_version_ 1721429867346526208

Similar Items